Company Filing History:
Years Active: 2023-2024
Title: The Innovative Contributions of Thorsten Brenner
Introduction
Thorsten Brenner is a notable inventor based in Morlenbach, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of invasive fungal infections. With a total of 2 patents to his name, his work has the potential to greatly impact patient care and treatment outcomes.
Latest Patents
Brenner's latest patents focus on innovative methods for diagnosing and managing invasive fungal infections. One of his patents, titled "Biomarkers for the diagnosis of invasive fungal infections," outlines a method for diagnosing, prognosing, and monitoring fungal infections. This invention is particularly relevant for patients at high risk of developing such infections, including those in critical health states like sepsis. The method involves determining the levels of specific markers, including ICAM1, AHSG, and others, to assess the presence and severity of the infection.
Another significant patent by Brenner is "Diagnosis and risk stratification of fungal infections." This invention details a method for diagnosing invasive fungal infections associated with sepsis or septic shock. It emphasizes the determination of the marker proadrenomedullin (proADM) or its fragments, which can be crucial for effective patient assessment and treatment planning.
Career Highlights
Thorsten Brenner is currently associated with B.R.A.H.M.S GmbH, a company known for its advancements in medical diagnostics. His work at the company has been instrumental in developing innovative diagnostic tools that enhance the understanding and management of fungal infections.
Collaborations
Brenner collaborates with esteemed colleagues such as Markus Weigand and Janin Schulte. Their combined expertise contributes to the advancement of diagnostic methods and the overall improvement of patient care in the field of infectious diseases.
Conclusion
Thorsten Brenner's contributions to the field of medical diagnostics, particularly through his patents on invasive fungal infections, highlight his role as an innovative inventor. His work not only enhances diagnostic accuracy but also improves treatment strategies for patients at risk of severe infections.